Early esophageal cancer

Levine, Marc S.; Dillon, E.; Saul, Scott H.; Laufer, Igor

doi:10.2214/ajr.146.3.507

Cited by 48 publications

(7 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These tumors may appear as plaque-like lesions (Fig. 7) or as flat, sessile polyps [69]. In patients with peptic strictures, the earliest manifestation of a developing adenocarcinoma may be a localized area of flattening or stiffening in one wall of the stricture.…”

Section: Esophageal Adenocarcinomamentioning

confidence: 99%

“…In patients with peptic strictures, the earliest manifestation of a developing adenocarcinoma may be a localized area of flattening or stiffening in one wall of the stricture. Other patients may have superficial spreading cancers with diffuse nodularity of the mucosa but no focal lesion [69]. Rarely, early cancers may be manifested by relatively large polypoid masses that are indistinguishable radiographically from advanced adenocarcinomas [69].…”

Section: Esophageal Adenocarcinomamentioning

confidence: 99%

“…Other patients may have superficial spreading cancers with diffuse nodularity of the mucosa but no focal lesion [69]. Rarely, early cancers may be manifested by relatively large polypoid masses that are indistinguishable radiographically from advanced adenocarcinomas [69]. Advanced Barrett's carcinomas usually appear on barium studies as infiltrating (Fig.…”

Section: Esophageal Adenocarcinomamentioning

confidence: 99%

See 2 more Smart Citations

Barrett's esophagus and esophageal adenocarcinoma: the scope of the problem

1995

View full text Add to dashboard Cite

Section: Esophageal Adenocarcinomamentioning

confidence: 99%

Section: Esophageal Adenocarcinomamentioning

confidence: 99%

Section: Esophageal Adenocarcinomamentioning

confidence: 99%

See 1 more Smart Citation

Barrett's esophagus and esophageal adenocarcinoma: the scope of the problem

1995

View full text Add to dashboard Cite

“…Early esophageal cancers are usually small protruded lesions less than 3.5 cm in size. These tumors may manifest on doublecontrast studies as plaquelike lesions (often containing flat central ulcers) (Fig 21), sessile polyps with a smooth or slightly lobulated contour, or focal irregularities of the esophageal wall (56). Early adenocarcinomas may also manifest as a localized area of wall flattening or irregularity within a preexisting peptic stricture (53).…”

Section: Esophageal Carcinomamentioning

confidence: 99%

Diseases of the Esophagus: Diagnosis with Esophagography

Levine

Rubesin²

2005

Radiology

View full text Add to dashboard Cite

The barium esophagram is a valuable diagnostic test for evaluating structural and functional abnormalities of the esophagus. The study is usually performed as a multiphasic examination that includes upright double-contrast views with a high-density barium suspension, prone single-contrast views with a low-density barium suspension, and, not infrequently, mucosal-relief views with either density of barium suspension. The double-contrast phase optimizes the ability to detect inflammatory or neoplastic diseases, whereas the single-contrast phase optimizes the ability to detect hiatal hernias and lower esophageal rings or strictures. Fluoroscopic examination of the esophagus is also important for assessing motility disorders such as achalasia and diffuse esophageal spasm. This article is a review of gastroesophageal reflux disease, other types of esophagitis, benign and malignant esophageal tumors, varices, lower esophageal rings, diverticula, and esophageal motility disorders, all of which can be diagnosed with the aid of esophagography.

show abstract

“…Owing to recent improvements in diagnostic techniques, the incidence of early esophageal cancers has been increasing [1][2][3]. However, since the majority of patients with esophageal cancer tend to have widespread disease at the time of detection, esophageal cancer still remains one of the most difficult neoplasms to be controlled by surgery alone [4].…”

Section: Introductionmentioning

confidence: 99%

Recent advances in preoperative hyperthermochemoradiotherapy for patients with esophageal cancer

et al. 1998

View full text Add to dashboard Cite

Background and Objectives: Hyperthermochemoradiotherapy (HCR) has been performed on numerous patients with esophageal cancer. The purpose of this study is to demonstrate the recent advances in HCR. Methods: From 1965 to 1997, 294 patients given preoperative chemoradiotherapy (CR) or HCR were classified according to the anticancer agent that was administered (CR; group A given bleomycin (BLM); group B given cis-diamminedichloroplatinum (II) (CDDP), HCR; group C given BLM; and Group D given CDDP). The local response and the long-term results were investigated. Results: The cases in which CR or HCR was evaluated to be effective numbered 44 (48.4%) in group A, 22 (73.3%) in group B, 79 (63.7%) in group C, and 36 (73.5%) in group D. A significant difference was observed between groups A and B (P < 0.05). The highest incidence of markedly effective cases was observed in group D. The 5-year survival rates for the group A and B patients were 17.2% and 43.9%, respectively (P < 0.01), while the same rates for those of groups C and D were 25.6% and 57.8%, respectively (P < 0.05). Our results thus showed CDDP to have a greater effect than BLM, while HCR had a greater effect than CR. Conclusions: Preoperative HCR has improved thanks to recent advances in anticancer agents.

show abstract

Early esophageal cancer

Cited by 48 publications

References 8 publications

Barrett's esophagus and esophageal adenocarcinoma: the scope of the problem

Barrett's esophagus and esophageal adenocarcinoma: the scope of the problem

Diseases of the Esophagus: Diagnosis with Esophagography

Recent advances in preoperative hyperthermochemoradiotherapy for patients with esophageal cancer

Contact Info

Product

Resources

About